Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap12.60K
Market cap12.60K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.22
52 Week high$5.22
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
Syros Pharmaceuticals(SYRS) stock is priced at $0.00, giving the company a market capitalization of 12.6K.
Syros Pharmaceuticals(SYRS) stock opened on 2026-03-18 at —. The price climbed to — and dipped to —.
Syros Pharmaceuticals(SYRS) shares are trading with a volume of 0, against a daily average of 5.31M.
During the past year, Syros Pharmaceuticals(SYRS) stock moved between $0.65 at its lowest and $5.22 at its peak.
During the past year, Syros Pharmaceuticals(SYRS) stock moved between $0.65 at its lowest and $5.22 at its peak.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.